Optical Coherence Tomography (OCT) is a critical imaging modality for diagnosing ocular and systemic conditions, yet its accessibility is hindered by the need for specialized expertise and high computational demands. To address these challenges, we introduce ChatOCT, an offline-capable, domain-adaptive clinical decision support system (CDSS) that integrates structured expert Q&A generation, OCT-specific knowledge injection, and activation-aware model compression. Unlike existing systems, ChatOCT functions without internet access, making it suitable for low-resource environments. ChatOCT is built upon LLaMA-2-7B, incorporating domain-specific knowledge from PubMed and OCT News through a two-stage training process: (1) knowledge injection for OCT-specific expertise and (2) Q&A instruction tuning for structured, interactive diagnostic reasoning. To ensure feasibility in offline environments, we apply activation-aware weight quantization, reducing GPU memory usage to ~ 4.74 GB, enabling deployment on standard OCT hardware. A novel expert answer generation framework mitigates hallucinations by structuring responses in a multi-step process, ensuring accuracy and interpretability. ChatOCT outperforms state-of-the-art baselines such as LLaMA-2, PMC-LLaMA-13B, and ChatDoctor by 10-15 points in coherence, relevance, and clinical utility, while reducing GPU memory requirements by 79%, while maintaining real-time responsiveness (~ 20 ms inference time). Expert ophthalmologists rated ChatOCT's outputs as clinically actionable and aligned with real-world decision-making needs, confirming its potential to assist frontline healthcare providers. ChatOCT represents an innovative offline clinical decision support system for optical coherence tomography (OCT) that runs entirely on local embedded hardware, enabling real-time analysis in resource-limited settings without internet connectivity. By offering a scalable, generalizable pipeline that integrates knowledge injection, instruction tuning, and model compression, ChatOCT provides a blueprint for next-generation, resource-efficient clinical AI solutions across multiple medical domains.

Timely intervention for Alzheimers disease (AD) requires early detection. The development of immunotherapies targeting amyloid-beta and tau underscores the need for accessible, time-efficient biomarkers for early diagnosis. Here, we directly applied our previously developed MRI-based deep learning model for AD to the large Chinese SILCODE cohort (722 participants, 1,105 brain MRI scans). The model -- initially trained on North American data -- demonstrated robust cross-ethnic generalization, without any retraining or fine-tuning, achieving an AUC of 91.3% in AD classification with a sensitivity of 95.2%. It successfully identified 86.7% of individuals at risk of AD progression more than 5 years in advance. Individuals identified as high-risk exhibited significantly shorter median progression times. By integrating an interpretable deep learning brain risk map approach, we identified AD brain subtypes, including an MCI subtype associated with rapid cognitive decline. The models risk scores showed significant correlations with cognitive measures and plasma biomarkers, such as tau proteins and neurofilament light chain (NfL). These findings underscore the exceptional generalizability and clinical utility of MRI-based deep learning models, especially in large and diverse populations, offering valuable tools for early therapeutic intervention. The model has been made open-source and deployed to a free online website for AD risk prediction, to assist in early screening and intervention.

Cardiac Magnetic Resonance (CMR) imaging is a vital non-invasive tool for diagnosing heart diseases and evaluating cardiac health. However, the limited availability of large-scale, high-quality CMR datasets poses a major challenge to the effective application of artificial intelligence (AI) in this domain. Even the amount of unlabeled data and the health status it covers are difficult to meet the needs of model pretraining, which hinders the performance of AI models on downstream tasks. In this study, we present Cardiac Phenotype-Guided CMR Generation (CPGG), a novel approach for generating diverse CMR data that covers a wide spectrum of cardiac health status. The CPGG framework consists of two stages: in the first stage, a generative model is trained using cardiac phenotypes derived from CMR data; in the second stage, a masked autoregressive diffusion model, conditioned on these phenotypes, generates high-fidelity CMR cine sequences that capture both structural and functional features of the heart in a fine-grained manner. We synthesized a massive amount of CMR to expand the pretraining data. Experimental results show that CPGG generates high-quality synthetic CMR data, significantly improving performance on various downstream tasks, including diagnosis and cardiac phenotypes prediction. These gains are demonstrated across both public and private datasets, highlighting the effectiveness of our approach. Code is availabel at https://anonymous.4open.science/r/CPGG.

Accurate classification of focal liver lesions is crucial for diagnosis and treatment in hepatology. However, traditional supervised deep learning models depend on large-scale annotated datasets, which are often limited in medical imaging. Recently, Vision-Language models (VLMs) such as Contrastive Language-Image Pre-training model (CLIP) has been applied to image classifications. Compared to the conventional convolutional neural network (CNN), which classifiers image based on visual information only, VLM leverages multimodal learning with text and images, allowing it to learn effectively even with a limited amount of labeled data. Inspired by CLIP, we pro-pose a Liver-VLM, a model specifically designed for focal liver lesions (FLLs) classification. First, Liver-VLM incorporates class information into the text encoder without introducing additional inference overhead. Second, by calculating the pairwise cosine similarities between image and text embeddings and optimizing the model with a cross-entropy loss, Liver-VLM ef-fectively aligns image features with class-level text features. Experimental results on MPCT-FLLs dataset demonstrate that the Liver-VLM model out-performs both the standard CLIP and MedCLIP models in terms of accuracy and Area Under the Curve (AUC). Further analysis shows that using a lightweight ResNet18 backbone enhances classification performance, particularly under data-constrained conditions.

Nuclear medicine is rapidly evolving with new molecular imaging targets and advanced computational tools that promise to enhance diagnostic precision and personalized therapy. Recent years have seen a surge in novel PET and SPECT tracers, such as those targeting prostate-specific membrane antigen (PSMA) in prostate cancer, fibroblast activation protein (FAP) in tumor stroma, and tau protein in neurodegenerative disease. These tracers enable more specific visualization of disease processes compared to traditional agents, fitting into a broader shift toward precision imaging in oncology and neurology. In parallel, artificial intelligence (AI) and machine learning techniques are being integrated into tracer development and image analysis. AI-driven methods can accelerate radiopharmaceutical discovery, optimize pharmacokinetic properties, and assist in interpreting complex imaging datasets. This editorial provides an expanded overview of emerging imaging targets and techniques, including theranostic applications that pair diagnosis with radionuclide therapy, and examines how AI is augmenting nuclear medicine. We discuss the implications of these advancements within the field's historical trajectory and address the regulatory, manufacturing, and clinical challenges that must be navigated. Innovations in molecular targeting and AI are poised to transform nuclear medicine practice, enabling more personalized diagnostics and radiotheranostic strategies in the era of precision healthcare.

Chest X-ray (CXR) is a diagnostic tool for cardiothoracic assessment. They make up 50% of all diagnostic imaging tests. With hundreds of images examined every day, radiologists can suffer from fatigue. This fatigue may reduce diagnostic accuracy and slow down report generation. We describe a prototype computer-assisted diagnosis (CAD) pipeline employing computer vision (CV) and Natural Language Processing (NLP). It was trained and evaluated on the publicly available MIMIC-CXR dataset. We perform image quality assessment, view labelling, and segmentation-based cardiomegaly severity classification. We use the output of the severity classification for large language model-based report generation. Four board-certified radiologists assessed the output accuracy of our CAD pipeline. Across the dataset composed of 377,100 CXR images and 227,827 free-text radiology reports, our system identified 0.18% of cases with mixed-sex mentions, 0.02% of poor quality images (F1 = 0.81), and 0.28% of wrongly labelled views (accuracy 99.4%). We assigned views for 4.18% of images which have unlabelled views. Our binary cardiomegaly classification model has 95.2% accuracy. The inter-radiologist agreement on evaluating the generated report's semantics and correctness for radiologist-MIMIC is 0.62 (strict agreement) and 0.85 (relaxed agreement) similar to the radiologist-CAD agreement of 0.55 (strict) and 0.93 (relaxed). Our work found and corrected several incorrect or missing metadata annotations for the MIMIC-CXR dataset. The performance of our CAD system suggests performance on par with human radiologists. Future improvements revolve around improved text generation and the development of CV tools for other diseases.

Despite significant progress in applying large language models (LLMs) to the medical domain, several limitations still prevent them from practical applications. Among these are the constraints on model size and the lack of cohort-specific labeled datasets. In this work, we investigated the potential of improving a lightweight LLM, such as Llama 3.1-8B, through fine-tuning with datasets using synthetic labels. Two tasks are jointly trained by combining their respective instruction datasets. When the quality of the task-specific synthetic labels is relatively high (e.g., generated by GPT4-o), Llama 3.1-8B achieves satisfactory performance on the open-ended disease detection task, with a micro F1 score of 0.91. Conversely, when the quality of the task-relevant synthetic labels is relatively low (e.g., from the MIMIC-CXR dataset), fine-tuned Llama 3.1-8B is able to surpass its noisy teacher labels (micro F1 score of 0.67 v.s. 0.63) when calibrated against curated labels, indicating the strong inherent underlying capability of the model. These findings demonstrate the potential offine-tuning LLMs with synthetic labels, offering a promising direction for future research on LLM specialization in the medical domain.

Radiology has usually been the field of medicine that has been at the forefront of technological advances, often being the first to wholeheartedly embrace them. Whether it's from digitization to cloud side architecture, radiology has led the way for adopting the latest advances. With the advent of large language models (LLMs), especially with the unprecedented explosion of freely available ChatGPT, time is ripe for radiology and radiologists to find novel ways to use the technology to improve their workflow. Towards this, we believe these LLMs have a key role in the radiology reading room not only to expedite processes, simplify mundane and archaic tasks, but also to increase the radiologist's and radiologist trainee's knowledge base at a far faster pace. In this article, we discuss some of the ways we believe ChatGPT, and the likes can be harnessed in the reading room.

Lung cancer imaging plays a crucial role in early diagnosis and treatment, where machine learning and deep learning have significantly advanced the accuracy and efficiency of disease classification. This study introduces the Explainable and Lightweight Lung Cancer Net (XLLC-Net), a streamlined convolutional neural network designed for classifying lung cancer from histopathological images. Using the LC25000 dataset, which includes three lung cancer classes and two colon cancer classes, we focused solely on the three lung cancer classes for this study. XLLC-Net effectively discerns complex disease patterns within these classes. The model consists of four convolutional layers and contains merely 3 million parameters, considerably reducing its computational footprint compared to existing deep learning models. This compact architecture facilitates efficient training, completing each epoch in just 60 seconds. Remarkably, XLLC-Net achieves a classification accuracy of 99.62% [Formula: see text] 0.16%, with precision, recall, and F1 score of 99.33% [Formula: see text] 0.30%, 99.67% [Formula: see text] 0.30%, and 99.70% [Formula: see text] 0.30%, respectively. Furthermore, the integration of Explainable AI techniques, such as Saliency Map and GRAD-CAM, enhances the interpretability of the model, offering clear visual insights into its decision-making process. Our results underscore the potential of lightweight DL models in medical imaging, providing high accuracy and rapid training while ensuring model transparency and reliability.

Early and accurate detection of COVID-19 and pneumonia through medical imaging is critical for effective patient management. This study aims to develop a robust framework that integrates synthetic image augmentation with advanced deep learning (DL) models to address dataset imbalance, improve diagnostic accuracy, and enhance trust in artificial intelligence (AI)-driven diagnoses through Explainable AI (XAI) techniques. The proposed framework benchmarks state-of-the-art models (InceptionV3, DenseNet, ResNet) for initial performance evaluation. Synthetic images are generated using Feature Interpolation through Linear Mapping and principal component analysis to enrich dataset diversity and balance class distribution. YOLOv8 and InceptionV3 models, fine-tuned via transfer learning, are trained on the augmented dataset. Grad-CAM is used for model explainability, while large language models (LLMs) support visualization analysis to enhance interpretability. YOLOv8 achieved superior performance with 97% accuracy, precision, recall, and F1-score, outperforming benchmark models. Synthetic data generation effectively reduced class imbalance and improved recall for underrepresented classes. Comparative analysis demonstrated significant advancements over existing methodologies. XAI visualizations (Grad-CAM heatmaps) highlighted anatomically plausible focus areas aligned with clinical markers of COVID-19 and pneumonia, thereby validating the model's decision-making process. The integration of synthetic data generation, advanced DL, and XAI significantly enhances the detection of COVID-19 and pneumonia while fostering trust in AI systems. YOLOv8's high accuracy, coupled with interpretable Grad-CAM visualizations and LLM-driven analysis, promotes transparency crucial for clinical adoption. Future research will focus on developing a clinically viable, human-in-the-loop diagnostic workflow, further optimizing performance through the integration of transformer-based language models to improve interpretability and decision-making.